Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder:: Evaluation in a controlled clinical trial
Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder:: Evaluation in a controlled clinical trial
复制标题
DOI：
10.1037/0022-006x.68.6.957
复制
发表时间：
2000-12-01
影响因子：
5.9
通讯作者：
Thibodeau, N
中科院分区：
文献类型：
--
作者：
Ladouceur, R;Dugas, MJ;Thibodeau, N
对焦虑的理解的最新进展导致了广泛性焦虑症（GAD）治疗的发展。本研究测试了广泛性焦虑症的治疗，针对不容忍的不确定性，错误的信念担心，穷人的问题导向，认知回避。将26例原发性广泛性焦虑患者随机分配至治疗条件（n = 14）或延迟治疗对照条件（n = 12）。自我报告、临床医生和其他重要评级评估了GAD和相关症状。结果表明，治疗导致了统计学和临床上显着的变化后，在6个月和12个月的随访中保持增益。此外，26名参与者中有20名（77%）在治疗后不再符合GAD诊断标准。关于治疗的基础模型，结果表明，不容忍的不确定性显着降低治疗和收益保持在两个后续行动。虽然非特异性因素不是治疗结果的重要预测因素，但它们在广泛性焦虑症治疗中的作用需要进一步研究。
Recent advances in the understanding of worry have led to the development of treatments for generalized anxiety disorder (GAD). The present study tested a GAD treatment that targeted intolerance of uncertainty, erroneous beliefs about worry, poor problem orientation, and cognitive avoidance. Twenty-six primary GAD patients were randomly allocated to a treatment condition (n = 14)or a delayed treatment control condition (n = 12). Self-report, clinician, and significant other ratings assessed GAD and associated symptoms. The results show that the treatment led to statistically and clinically significant change at posttest and that gains were maintained at 6- and 12-month follow-ups. Furthermore, 20 of 26 participants (77%) no longer met GAD diagnostic criteria following treatment. With regard to the treatment's underlying model, the results show that intolerance of uncertainty significantly decreased over treatment and that gains were maintained at both follow-ups. Although nonspecific factors were not significant predictors of treatment outcome, their role in the treatment of GAD requires further investigation.